Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00566150 · ClinicalTrials.gov registry record · NA
Levetiracetam in the Management of Bipolar Depression
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 35
- Enrollment target
NCT00566150 is a NA study that has completed, run by Yale University. The registered enrollment target is 35 participants.
The verdict
NCT00566150, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 35 participants
- Enrollment target
Study Summary
A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.
Interventions
- DRUG Placebo
- DRUG Levetiracetam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2005-10 |
| Est. Completion | 2008-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00566150
The ClinicalTrials.gov registry entry for NCT00566150 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00566150 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00566150 about?
NCT00566150 is a clinical study titled "Levetiracetam in the Management of Bipolar Depression". A 6-week outpatient, double-blind, placebo-controlled, add-on trial to investigate the effects of levetiracetam on depressive symptoms in bipolar depressed patients.
What is the current status of trial NCT00566150?
This trial is currently completed. It is a NA study. The enrollment target is 35 participants. The study started on 2005-10. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00566150?
The interventions under investigation include: Placebo (DRUG), Levetiracetam (DRUG).
Who is sponsoring clinical trial NCT00566150?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.